IRCT20151021024645N3招募中2 期
The application of metformin in protecting chemotherapy-induced neuropathy in patients with breast cancer
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- Female
入选标准
- •Patients affected with breast cancer, based on the biopsy findings,
排除标准
- •Active diabetic patients or those with a history of diabetes
- •The history of neuropathy or nerve damage
- •The history of chemotherapeutic agent use
- •Hyperthyroidism or thyrotoxicosis
- •The patient with digestive problems who may less likely tolerate metformin
- •The patients with contraindications for metformin treatment
研究者
相似试验
招募中
3 期
Evaluation of the Protective Effect of Metformin against the Tamoxifen Induced Changes on Endometrium and OvariesIRCT20140820018866N9Tehran University of Medical Sciences100
招募中
3 期
The effect of the metformin in preventing of the preeclampsiaon severe preeclampsia.Mild to moderate pre-eclampsia, unspecified trimesterO14.00IRCT20210316050725N1Iran University of Medical Sciences52
进行中（未招募）
1 期
Efficacity and safety of metformin extended release (XR) in diabetic patients with CKD in stages 1 to 3 (METXR/CKD)type 2 diabetesMedDRA version: 19.0Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2016-001233-27-FRCHU Amiens Picardie12
尚未招募
4 期
A study to evaluate the role of metformin in preventing the incidence and complications of superimposed pre-eclampsia in chronic hypertensive patientsCTRI/2024/01/061712Thanjavur medical college
招募中
2 期
Metformin as an adjuvant therapy for autismIRCT20090117001556N156Tehran University of Medical Sciences50